Investor Relations Corporate Profile Evolus is a medical aesthetics company focused on providing physicians and their patients with expanded choices in medical aesthetic treatments and procedures. FINANCIAL NEWS February 4, 2019 Evolus to Hold Conference Call Following Jeuveau™ FDA Approval February 1, 2019 Evolus Receives FDA Approval for Jeuveau™ prabotulinumtoxinA-xvfs for Injection December 19, 2018 Evolus Added to NASDAQ Biotechnology Index View all EVENTS Call to Discuss Jeuveau™ FDA Approval Feb 4, 2019 at 8:00 AM EST Stifel 2018 Healthcare Conference Nov 13, 2018 at 8:00 AM EST Q3 2018 Evolus Earnings Conference Call Nov 5, 2018 at 4:30 PM EST View all PRESENTATION February 2019 Investor Presentation Feb 19, 2019 Jeuveau™ FDA Approval Presentation Feb 04, 2019
